Elfatih O. Elzein

Person

Freemont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cannabinoid receptor type 2 (CB2) modulators and uses thereof
- Patent number 11,957,689
- Issue date Apr 16, 2024
- Teon Therapeutics, Inc.
- Elfatih Elzein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cannabinoid receptor type 2 (CB2) modulators and uses thereof
- Patent number 11,564,928
- Issue date Jan 31, 2023
- Teon Therapeutics, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,229,638
- Issue date Jan 25, 2022
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenosine receptor antagonists and uses thereof
- Patent number 11,124,515
- Issue date Sep 21, 2021
- Teon Therapeutics, Inc.
- Jiwen Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,098,027
- Issue date Aug 24, 2021
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,040,033
- Issue date Jun 22, 2021
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(N-pyrazolo)adenosines with application as adenosine A2A receptor...
- Patent number RE47351
- Issue date Apr 16, 2019
- Gilead Sciences, Inc.
- Jeff A. Zablocki
Information Patent Grant
Process for preparing an A2A-adenosine receptor agonist and its pol...
- Patent number RE47301
- Issue date Mar 19, 2019
- Gilead Sciences, Inc.
- Jeff Zablocki
Information Patent Grant
Fused heterocyclic compounds as CaM kinase inhibitors
- Patent number 10,100,058
- Issue date Oct 16, 2018
- Gilead Sciences, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,695,192
- Issue date Jul 4, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,682,998
- Issue date Jun 20, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,676,760
- Issue date Jun 13, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,598,435
- Issue date Mar 21, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,403,782
- Issue date Aug 2, 2016
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,371,329
- Issue date Jun 21, 2016
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,193,694
- Issue date Nov 24, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,115,096
- Issue date Aug 25, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing an A2A-adenosine receptor agonist and its pol...
- Patent number 9,085,601
- Issue date Jul 21, 2015
- Gilead Sciences, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-pyrazole A2A receptor agonists
- Patent number 9,045,519
- Issue date Jun 2, 2015
- Gilead Sciences, Inc.
- Jeff A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,962,610
- Issue date Feb 24, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,952,034
- Issue date Feb 10, 2015
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,754,103
- Issue date Jun 17, 2014
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,697,863
- Issue date Apr 15, 2014
- Gilead Sciences, Inc.
- Elfatih Elzein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,586,732
- Issue date Nov 19, 2013
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-pyrazole A2A receptor agonists
- Patent number 8,569,260
- Issue date Oct 29, 2013
- Gilead Sciences, Inc.
- Jeff A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)o...
- Patent number 8,524,883
- Issue date Sep 3, 2013
- Gilead Sciences, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,389,500
- Issue date Mar 5, 2013
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 8,324,224
- Issue date Dec 4, 2012
- Gilead Sciences, Inc.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-pyrazole A2A receptor agonists
- Patent number 8,278,435
- Issue date Oct 2, 2012
- Gilead Sciences, Inc.
- Jeff A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing an A2A-adenosine receptor agonist and its pol...
- Patent number 8,268,988
- Issue date Sep 18, 2012
- Gilead Sciences, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF
- Publication number 20240252504
- Publication date Aug 1, 2024
- Teon Therapeutics, Inc.
- Elfatih ELZEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE
- Publication number 20240140980
- Publication date May 2, 2024
- Teon Therapeutics, Inc.
- Elfatih ELZEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE
- Publication number 20240140979
- Publication date May 2, 2024
- Teon Therapeutics, Inc.
- Elfatih ELZEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20240041889
- Publication date Feb 8, 2024
- Teon Therapeutics, Inc.
- PEIDONG FAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF
- Publication number 20230143502
- Publication date May 11, 2023
- Teon Therapeutics, Inc.
- Elfatih ELZEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADENOSINE A2A RECEPTOR ANTAGONISTS
- Publication number 20230024108
- Publication date Jan 26, 2023
- Teon Therapeutics, Inc.
- Elfatih ELZEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20220056033
- Publication date Feb 24, 2022
- Teon Therapeutics, Inc.
- Jiwen Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20210163483
- Publication date Jun 3, 2021
- Teon Therapeutics, Inc.
- Jiwen Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20210040097
- Publication date Feb 11, 2021
- Teon Therapeutics, Inc.
- Jiwen LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC HETEROCYCLIC COMPOUNDS
- Publication number 20200316035
- Publication date Oct 8, 2020
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC HETEROCYCLIC COMPOUNDS
- Publication number 20200031801
- Publication date Jan 30, 2020
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic heterocyclic compounds
- Publication number 20190192504
- Publication date Jun 27, 2019
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS
- Publication number 20180148457
- Publication date May 31, 2018
- GILEAD SCIENCES, INC.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160362421
- Publication date Dec 15, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160347744
- Publication date Dec 1, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160096846
- Publication date Apr 7, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20150329558
- Publication date Nov 19, 2015
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20150239904
- Publication date Aug 27, 2015
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140303158
- Publication date Oct 9, 2014
- GILEAD SCIENCES, INC.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...
- Publication number 20140213539
- Publication date Jul 31, 2014
- GILEAD SCIENCES, INC.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140135317
- Publication date May 15, 2014
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-Pyrazole A2A Receptor Agonists
- Publication number 20140073596
- Publication date Mar 13, 2014
- GILEAD SCIENCES, INC.
- Jeff A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130184255
- Publication date Jul 18, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2B ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20130123280
- Publication date May 16, 2013
- GILEAD SCIENCES, INC.
- Rao V. Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-PYRAZOLE A2A RECEPTOR AGONISTS
- Publication number 20130058866
- Publication date Mar 7, 2013
- GILEAD SCIENCES, INC.
- Jeff A. Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130012492
- Publication date Jan 10, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130005706
- Publication date Jan 3, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20120289493
- Publication date Nov 15, 2012
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...
- Publication number 20120165350
- Publication date Jun 28, 2012
- GILEAD SCIENCES, INC.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...
- Publication number 20110257387
- Publication date Oct 20, 2011
- GILEAD SCIENCES, INC.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY

Elfatih O. Elzein

Person

Patents Grantslast 30 patents

Cannabinoid receptor type 2 (CB2) modulators and uses thereof

Cannabinoid receptor type 2 (CB2) modulators and uses thereof

Therapeutic heterocyclic compounds

Adenosine receptor antagonists and uses thereof

Therapeutic heterocyclic compounds

Therapeutic heterocyclic compounds

2-(N-pyrazolo)adenosines with application as adenosine A2A receptor...

Process for preparing an A2A-adenosine receptor agonist and its pol...

Fused heterocyclic compounds as CaM kinase inhibitors

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Process for preparing an A2A-adenosine receptor agonist and its pol...

N-pyrazole A2A receptor agonists

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

N-pyrazole A2A receptor agonists

Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)o...

Fused heterocyclic compounds as ion channel modulators

A2B adenosine receptor antagonists

N-pyrazole A2A receptor agonists

Process for preparing an A2A-adenosine receptor agonist and its pol...

Patents Applicationslast 30 patents

CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF

HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE

HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE

COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS

CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF

ADENOSINE A2A RECEPTOR ANTAGONISTS

ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF

ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF

ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF

THERAPEUTIC HETEROCYCLIC COMPOUNDS

THERAPEUTIC HETEROCYCLIC COMPOUNDS

Therapeutic heterocyclic compounds

FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

N-Pyrazole A2A Receptor Agonists

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

A2B ADENOSINE RECEPTOR ANTAGONISTS

N-PYRAZOLE A2A RECEPTOR AGONISTS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...

PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POL...